Clik here to view.
Advising on the proposed US$1.08 billion takeover of Montreal biotech Enobia...
As recently as five months ago, an executive of Montreal drug developer Enobia Pharma Inc. publicly mused that possible plans to publicly list in the United States could make it an acquisition target...
View ArticleClik here to view.
Opinion: Health Canada fails to enforce its own rules on pharmaceutical...
A handsome man struts over to the office water cooler with a smirk on his face. When his colleagues ask about his weekend, he replies enthusiastically, with audio muted. A large blue pill appears with...
View ArticleClik here to view.
Opinion: It's now possible to envision a future without Hepatitis C
A year ago, Quebec announced a plan to roll out public access to new Hepatitis C therapies, prioritizing those with the most advanced disease, and laying out a sound plan to eventually offer treatment...
View ArticleClik here to view.
Opinion: Answering the difficult questions about drug safety
The Hippocatic oath says “I will use medicine to help the sick … but never with a view to injury.” That poses a unique problem for physicians because all medications have the power to heal and the...
View Article